WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TENX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$7.7M
Current Profit Margin
0%

TENX Return on Equity

Current Company
-65.8%
Current Industry
-63.5%
Current Market
188%
TENX's Return on Equity (-65.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TENX announces earnings.

TENX Return on Assets

Current Company
-58.3%
Current Industry
2.9%
TENX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TENX Return on Capital Employed

Current Company
-94.92%
Current Industry
19.5%
TENX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TENX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TENX$0.00-$7.68M-$7.71MN/AN/A
CHRO$0.00-$6.86M-$7.38M-100.00%N/A
PSTV$4.91M-$12.18M-$13.32M+10.49%N/A
PULM$7.30M-$12.65M-$14.12M+116.62%N/A
PYPD$0.00-$21.05M-$23.87MN/A+28.76%
View Top Biotech Stocks

TENX earnings dates

Next earnings date
May 13, 2024

Tenax Therapeutics Earnings & Revenue FAQ

What were TENX's earnings last quarter?

On Invalid Date, Tenax Therapeutics (NASDAQ: TENX) reported Q4 2023 earnings per share (EPS) of -$11.84, up 82.97% year over year. Total Tenax Therapeutics earnings for the quarter were -$3.23 million. In the same quarter last year, Tenax Therapeutics's earnings per share (EPS) was -$69.51.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.

What was TENX's earnings growth in the past year?

As of Q2 2024, Tenax Therapeutics's earnings has grown year over year. Tenax Therapeutics's earnings in the past year totalled -$7.71 million.

What is TENX's earnings date?

Tenax Therapeutics's earnings date is Invalid Date. Add TENX to your watchlist to be reminded of TENX's next earnings announcement.

What was TENX's revenue last quarter?

On Invalid Date, Tenax Therapeutics (NASDAQ: TENX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Tenax Therapeutics's revenue was $0.00.

What was TENX's revenue growth in the past year?

As of Q2 2024, Tenax Therapeutics's revenue has grown null year over year. Tenax Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.